The medication alirocumab, a PCSK9 inhibitor, reduces LDL cholesterol levels as well as non-high-density lipoprotein cholesterol (non-HDL-C) in patients with type 2 diabetes, according to two...

Data presented at the 77th Scientific Sessions of the American Diabetes Association (ADA) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive results from two Phase...

Royal Philips (NSYE: PHG, AEX: PHIA) today announced that it will be showcasing molecular imaging solutions highlighting Philips' commitment to innovation and more personalized care at the Society...

On June 6, 2017, the 9th China International New Energy Expo & Energy Storage and Multi-energy Complementarity Summit Forum (CNEE) kicked off at China International Exhibition Center in Beijing....

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE...